ARDENT HEALTH PARTNERS INC (ARDT) Stock Fundamental Analysis
NYSE:ARDT - New York Stock Exchange, Inc. - US03980N1072 - Common Stock - Currency: USD
ARDT gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 105 industry peers in the Health Care Providers & Services industry. ARDT has only an average score on both its financial health and profitability. A decent growth rate in combination with a cheap valuation! Better keep an eye on ARDT.
1. Profitability
1.1 Basic Checks
In the past year ARDT was profitable.
ARDT had a positive operating cash flow in the past year.
1.2 Ratios
The Return On Assets of ARDT (4.24%) is better than 73.33% of its industry peers.
The Return On Equity of ARDT (18.59%) is better than 85.71% of its industry peers.
The Return On Invested Capital of ARDT (8.48%) is better than 78.10% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for ARDT is below the industry average of 8.81%.
The 3 year average ROIC (5.96%) for ARDT is below the current ROIC(8.48%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.24% | ||
| ROE | 18.59% | ||
| ROIC | 8.48% |
ROA(3y)3.2%
ROA(5y)N/A
ROE(3y)18.73%
ROE(5y)N/A
ROIC(3y)5.96%
ROIC(5y)N/A
1.3 Margins
ARDT has a better Profit Margin (3.53%) than 71.43% of its industry peers.
In the last couple of years the Profit Margin of ARDT has grown nicely.
ARDT's Operating Margin of 6.80% is fine compared to the rest of the industry. ARDT outperforms 71.43% of its industry peers.
In the last couple of years the Operating Margin of ARDT has grown nicely.
ARDT has a better Gross Margin (57.51%) than 79.05% of its industry peers.
In the last couple of years the Gross Margin of ARDT has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.8% | ||
| PM (TTM) | 3.53% | ||
| GM | 57.51% |
OM growth 3Y3%
OM growth 5YN/A
PM growth 3Y3.64%
PM growth 5YN/A
GM growth 3Y2.83%
GM growth 5YN/A
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), ARDT is creating some value.
Compared to 1 year ago, ARDT has more shares outstanding
The debt/assets ratio for ARDT has been reduced compared to a year ago.
2.2 Solvency
An Altman-Z score of 2.07 indicates that ARDT is not a great score, but indicates only limited risk for bankruptcy at the moment.
ARDT has a Altman-Z score (2.07) which is in line with its industry peers.
The Debt to FCF ratio of ARDT is 8.59, which is on the high side as it means it would take ARDT, 8.59 years of fcf income to pay off all of its debts.
ARDT has a Debt to FCF ratio (8.59) which is comparable to the rest of the industry.
A Debt/Equity ratio of 0.96 indicates that ARDT is somewhat dependend on debt financing.
ARDT's Debt to Equity ratio of 0.96 is on the low side compared to the rest of the industry. ARDT is outperformed by 63.81% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.96 | ||
| Debt/FCF | 8.59 | ||
| Altman-Z | 2.07 |
ROIC/WACC1.1
WACC7.73%
2.3 Liquidity
ARDT has a Current Ratio of 1.94. This is a normal value and indicates that ARDT is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Current ratio value of 1.94, ARDT is doing good in the industry, outperforming 72.38% of the companies in the same industry.
ARDT has a Quick Ratio of 1.82. This is a normal value and indicates that ARDT is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.82, ARDT is in the better half of the industry, outperforming 69.52% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.94 | ||
| Quick Ratio | 1.82 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 314.38% over the past year.
ARDT shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 13.75% yearly.
ARDT shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 10.29%.
Measured over the past years, ARDT shows a small growth in Revenue. The Revenue has been growing by 7.00% on average per year.
EPS 1Y (TTM)314.38%
EPS 3Y13.75%
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)10.29%
Revenue growth 3Y7%
Revenue growth 5YN/A
Sales Q2Q%N/A
3.2 Future
ARDT is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 21.52% yearly.
Based on estimates for the next years, ARDT will show a small growth in Revenue. The Revenue will grow by 6.61% on average per year.
EPS Next Y56.98%
EPS Next 2Y28.6%
EPS Next 3Y21.52%
EPS Next 5YN/A
Revenue Next Year8.41%
Revenue Next 2Y7%
Revenue Next 3Y6.61%
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
ARDT is valuated cheaply with a Price/Earnings ratio of 7.61.
Compared to the rest of the industry, the Price/Earnings ratio of ARDT indicates a rather cheap valuation: ARDT is cheaper than 94.29% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 28.29. ARDT is valued rather cheaply when compared to this.
ARDT is valuated cheaply with a Price/Forward Earnings ratio of 5.91.
ARDT's Price/Forward Earnings ratio is rather cheap when compared to the industry. ARDT is cheaper than 96.19% of the companies in the same industry.
ARDT is valuated cheaply when we compare the Price/Forward Earnings ratio to 21.32, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 7.61 | ||
| Fwd PE | 5.91 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, ARDT is valued cheaper than 94.29% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, ARDT is valued a bit cheaper than the industry average as 78.10% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 12.77 | ||
| EV/EBITDA | 4.21 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of ARDT may justify a higher PE ratio.
ARDT's earnings are expected to grow with 21.52% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.13
PEG (5Y)N/A
EPS Next 2Y28.6%
EPS Next 3Y21.52%
5. Dividend
5.1 Amount
No dividends for ARDT!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NYSE:ARDT (4/21/2025, 2:28:53 PM)
11.41
-1.1 (-8.79%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners72.28%
Inst Owner Change0.02%
Ins Owners1.82%
Ins Owner Change1.47%
Market Cap1.63B
Analysts81.25
Price Target21.76 (90.71%)
Short Float %0.91%
Short Ratio2.36
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)15.96%
Min EPS beat(2)-44.28%
Max EPS beat(2)76.2%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)2%
Min Revenue beat(2)-2.11%
Max Revenue beat(2)6.1%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-1.23%
PT rev (3m)-5.6%
EPS NQ rev (1m)-21.2%
EPS NQ rev (3m)-49.1%
EPS NY rev (1m)-2.26%
EPS NY rev (3m)-5.29%
Revenue NQ rev (1m)-0.71%
Revenue NQ rev (3m)-2.05%
Revenue NY rev (1m)0.29%
Revenue NY rev (3m)0.51%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 7.61 | ||
| Fwd PE | 5.91 | ||
| P/S | 0.27 | ||
| P/FCF | 12.77 | ||
| P/OCF | 5.17 | ||
| P/B | 1.44 | ||
| P/tB | 8.05 | ||
| EV/EBITDA | 4.21 |
EPS(TTM)1.5
EY13.15%
EPS(NY)1.93
Fwd EY16.92%
FCF(TTM)0.89
FCFY7.83%
OCF(TTM)2.21
OCFY19.34%
SpS41.79
BVpS7.93
TBVpS1.42
PEG (NY)0.13
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.24% | ||
| ROE | 18.59% | ||
| ROCE | 10.12% | ||
| ROIC | 8.48% | ||
| ROICexc | 9.85% | ||
| ROICexgc | 13.47% | ||
| OM | 6.8% | ||
| PM (TTM) | 3.53% | ||
| GM | 57.51% | ||
| FCFM | 2.14% |
ROA(3y)3.2%
ROA(5y)N/A
ROE(3y)18.73%
ROE(5y)N/A
ROIC(3y)5.96%
ROIC(5y)N/A
ROICexc(3y)6.85%
ROICexc(5y)N/A
ROICexgc(3y)9.47%
ROICexgc(5y)N/A
ROCE(3y)7.12%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y3%
OM growth 5YN/A
PM growth 3Y3.64%
PM growth 5YN/A
GM growth 3Y2.83%
GM growth 5YN/A
F-Score8
Asset Turnover1.2
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.96 | ||
| Debt/FCF | 8.59 | ||
| Debt/EBITDA | 1.97 | ||
| Cap/Depr | 128.18% | ||
| Cap/Sales | 3.14% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 57.06% | ||
| Profit Quality | 60.62% | ||
| Current Ratio | 1.94 | ||
| Quick Ratio | 1.82 | ||
| Altman-Z | 2.07 |
F-Score8
WACC7.73%
ROIC/WACC1.1
Cap/Depr(3y)111.7%
Cap/Depr(5y)N/A
Cap/Sales(3y)2.88%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)314.38%
EPS 3Y13.75%
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y56.98%
EPS Next 2Y28.6%
EPS Next 3Y21.52%
EPS Next 5YN/A
Revenue 1Y (TTM)10.29%
Revenue growth 3Y7%
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year8.41%
Revenue Next 2Y7%
Revenue Next 3Y6.61%
Revenue Next 5YN/A
EBIT growth 1Y87.99%
EBIT growth 3Y10.2%
EBIT growth 5YN/A
EBIT Next Year71.2%
EBIT Next 3Y26.88%
EBIT Next 5YN/A
FCF growth 1Y51.28%
FCF growth 3Y152.66%
FCF growth 5YN/A
OCF growth 1Y42.1%
OCF growth 3Y28.95%
OCF growth 5YN/A